Clal Biotechnology reported ILS121.41M in Equity Capital and Reserves for its fiscal quarter ending in December of 2023.


Equity Capital And Reserves Change Date
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 50.26M 4.65M Jun/2025
Life Technologies USD 74.66M 4.64M Jun/2025
RedHill Biopharma USD -4683000 4.74M Dec/2024